Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-06-05

Clinical Trial Update: The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating whether light reduction affects Retinopathy of Prematurity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Retinopathy of Prematurity | Phase 3 | Status: COMPLETED